The global Adenovirus Services market size is predicted to grow from US$ 76.5 million in 2025 to US$ 98 million in 2031; it is expected to grow at a CAGR of 4.2% from 2025 to 2031.
Adenovirus service refers to the technical service of using adenovirus as a vector to introduce the target gene into the host cell. Adenovirus is a non-enveloped double-stranded DNA virus with advantages such as wide host range, high infection efficiency, and non-integration into the host genome. It is widely used in gene therapy, vaccine development, cancer treatment and gene editing.
This report presents a comprehensive overview, market shares, and growth opportunities of Adenovirus Services market by product type, application, key players and key regions and countries.
Key Features
- Last year market size: US$ 76.5 million in 2025.
- Forecasted market size: US$ 98 million in 2031.
- Expected growth at a CAGR of 4.2% from 2025 to 2031.
Segmentation by Type
- Replication Defective Adenovirus
- Conditionally Replicating Adenovirus
- Oncolytic Adenovirus
Segmentation by Application
- Gene Overexpression Research
- Vaccine Development
- Other
Market by Region
- Americas
- APAC
- Europe
- Middle East & Africa
Company's Coverage
- Vector Biolabs
- Creative Biolabs
- AMSBIO
- VectorBuilder
- AcceGen
- Creative Biogene
- abm
- SignaGen Laboratories
Key Questions Addressed in this Report
- What are the key trends impacting the market?
- Which companies are the key players in the market?
- What is the growth potential for the market in the next five years?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market